Tuesday, April 28, 2009

Prevention of transgene escape in genetically modified perennials: 7525015

Inventor(s): Luo Hong, Hu Qian, Vasilchik Kimberly Nelson, Longo John P, Kausch Albert P, Zilinskas Barbara, Lakkaraju Subha

Issued: 4/28/2009

Abstract: Genes can be introduced into plants that confer desirable traits such as, drought and stress tolerance, insect and pest resistance, as well as environmental qualities such as phyto-remediation. However, possibility for transgene escape to wild and non-transformed species raises commercial and ecological concerns. Disclosed herein are methods and compositions for generating sterile plants for the prevention of transgene escape.

The threat of transgene escape to other plants is a real concern, and control of this problem is important if transgenic perennial plants are released. Therefore, methods are needed that decrease or prevent the risk of spreading a transgene from a transgenic perennial into the environment through outcrossing. Disclosed herein are methods for generating sterile plants, such as male sterile plants, which decrease transgene escape. Sterile transgenic plants do not produce significant numbers of viable pollen grains, thus decreasing or preventing the potential risk of transgene escape into the surrounding environment by outcrossing with wild species.

Methods to generate sterile perennial plants, such as male and/or female sterile plants, are disclosed herein by functionally deleting floral structures, such as the tapetum. In one example, a cytotoxic molecule, such as a barnase gene or an anti-sense floral-specific gene, is driven by a floral-specific promoter creating defective floral structures, such as sterile pollen. For example, expression of the cytotoxin, that in one example produces a protein product that decreases the presence and/or production of tapetum, results in male sterility.
USPTO Webpage 7525015

Tuesday, April 21, 2009

Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix: 7521061

Inventor(s): Kohn Joachim B, Schachter Deborah M

Issued: 4/21/2009

Abstract: A formulation containing a biologically active compound having a structure with hydrogen bonding sites is blended with a polymer having a structure with complementary hydrogen bonding sites, the polymer forming hydrolytic degradation products that promote the release of the biologically active compound from the polymer.

USPTO Webpage 7521061

Tuesday, April 14, 2009

Topoisomerase-targeting agents: 7517867

Inventor(s): LaVoie Edmond J, Ruchelman Alexander L, Liu Leroy F

Issued: 4/14/2009

Abstract: The invention provides compounds of formula I or formula II: ##STR00001## wherein: the bond represented by -- is a single bond or a double bond, and R.sub.1-R.sub.5, X, and Y have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I or II, processes for preparing compounds of formula I or II, intermediates useful for preparing compounds of formula I or II, and therapeutic methods for treating cancer and other topoisomerase related conditions using compounds of formula I or II.

USPTO Webpage 7517867

Solubilized topoisomerase poisons: 7517883

Inventor(s): LaVoie Edmond J, Ruchelman Alexander L, Liu Leroy F

Issued: 4/14/2009

Abstract: The invention provides compounds of formula I: ##STR00001## whereinA, B, W, Y, Z, and R.sub.1 have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I, and therapeutic methods for treating cancer using compounds of formula I.

USPTO Webpage 7517883

Tuesday, March 17, 2009

Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof: 7504555

Inventor(s): Maliga Pal, Kuroda Hiroshi, Khan Muhammad Sarwar

Issued: 3/17/2009

Abstract: DNA constructs containing translational control elements are provided. These 5' regulatory segments facilitate high level expression of transgenes introduced into the plastids of higher plants.

USPTO Webpage 7504555

This invention relates to the fields of transgenic plants and molecular biology. More specifically, the invention provides vectors targeting the plastid genome which contain translation control elements facilitating high levels of protein expression in the plastids of higher plants. Both monocots and dicots are successfully transformed with the DNA constructs provided herein.

Tuesday, January 20, 2009

Power junction field effect power transistor with highly vertical channel and uniform channel opening: 7479672

Zhao Jian H

Inventor(s): Zhao Jian H

Issued: 1/20/2009

Abstract: A semiconductor vertical junction field effect power transistor formed by a semiconductor structure having top and bottom surfaces and including a plurality of semiconductor layers with predetermined doping concentrations and thicknesses and comprising at least a bottom layer as drain layer, a middle layer as blocking and channel layer, a top layer as source layer. A plurality of laterally spaced U-shaped trenches with highly vertical side walls defines a plurality of laterally spaced mesas. The mesas are surrounded on the four sides by U-shaped semiconductor regions having conductivity type opposite to that of the mesas forming U-shaped pn junctions and defining a plurality of laterally spaced long and vertical channels with a highly uniform channel opening dimension. A source contact is formed on the top source layer and a drain contact is formed on the bottom drain layer. A gate contact is formed on the bottom of the U-shaped trenches for the purpose of creating and interrupting the vertical channels so as to turn on and turn off the transistor.

USPTO Webpage 7479672

Tuesday, December 30, 2008

Micelle assemblies: 7470802

Inventor(s): Uhrich Kathryn E, Tian Lu

Issued: 12/30/2008

Abstract: The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. Also, the invention encompasses compounds of the formula: A-X-Y-Z-R.sub.1 wherein A is a carboxy group or is absent; X is a polyol, Y is --C(.dbd.O)--, --C(.dbd.S)--, or is absent; Z is O, S, or NH; and R.sub.1 is a polyether, wherein one or more hydroxy groups of the polyol are acylated with a fatty acid residue, wherein the compounds form micelle assemblies. The invention encompasses methods of encapsulating molecules using the compounds of the invention.

USPTO Webpage 7470802

Tuesday, December 23, 2008

Methods and kits for screening nucleic acid duplex stability: 7468250

Organic Compounds -- Part of the Class 532-570 Series,Breslauer Kenneth J, Gelfand Craig A, Plum Eric G

Inventor(s): Breslauer Kenneth J, Gelfand Craig A, Plum Eric G

Issued: 12/23/2008

Abstract: Simple methods and kits for determining the thermodynamic stability of nucleic acid duplexes and single polynucleotide polymorphisms via competitive equilibria are provided.

USPTO Webpage 7468250

Tuesday, November 18, 2008

Plastid promoters for transgene expression in the plastids of higher plants: 7452986

Chemistry: Natural Resins or Derivatives; Peptides or Proteins; Lignins or Reaction Products Thereof,Maliga Pal, Silhavy Daniel, Sriraman Priya

Inventor(s): Maliga Pal, Silhavy Daniel, Sriraman Priya

Issued: 11/18/2008

Abstract: The present invention provides promoter elements useful for stably transforming the plastids of higher plants. The constructs described herein contain unique promoters that are transcribed by both nuclear encoded plastid RNA polymerases, plastid encoded plastid RNA polymerases or both. Use of the novel constructs of the invention facilitates transformation of a wider range of plant species and enables ubiquitous expression of a transforming DNA in plastids of multicellular plants.

USPTO Webpage 7452986

Tuesday, October 28, 2008

Mutational derivatives of microcin J25: 7442762

Inventor(s): Severinov Konstantin, Ebright Richard, Pavlova Olga, Sineva Elena

Issued: 10/28/2008

Abstract: Analogs of bacteriocidal peptide microcin J25 (MccJ25) are provided that have an amino acid sequence that differs from that of MccJ25 by having at least one amino acid substitution; and that inhibit bacterial cell growth with a potency at least equal to that of MccJ25.

Applicants have discovered analogs of MccJ25 that are able to bind to bacterial RNAP, to inhibit bacterial RNAP, and to inhibit bacterial growth with a potency at least equal to that of mature MccJ25 (FIG. 1).

The present invention provides an analog of bacteriocidal peptide microcin J25 (MccJ25) that (1) has an amino acid sequence that differs from that of MccJ25 by having at least one amino acid substitution; and (2) that inhibits bacterial cell growth with a potency at least equal to that of MccJ25.

The present invention also provides a method of identifying at least one MccJ25 analog that inhibits growth of MccJ25-sensitive cells. This method includes growing MccJ25-sensitive cells in the presence of cells harboring a plasmid containing an MccJ25 analog, the analog having an amino acid sequence that differs from that of MccJ25 by having at least one amino acid substitution; and observing the presence or absence of cell growth inhibition, wherein the presence of cell growth inhibition indicates the presence of cells producing the MccJ25 analog that inhibits growth of MccJ25-sensitive cells.

The invention further provides a method of identifying at least one MccJ25 analog that inhibits cell growth of MccJ25-resistant cells. This method includes growing MccJ25-resistant cells in the presence of cells harboring a plasmid containing an MccJ25 analog, the analog having an amino acid sequence that differs from that of MccJ25 by having at least one amino acid substitution. The method also includes observing the presence or absence of cell growth inhibition, wherein the presence of cell growth inhibition indicates the presence of cells producing the MccJ25 analog that inhibits growth of MccJ25-resistant cells.

It is anticipated that compounds and methods of this invention would have applications not only in antibacterial therapy, but also in: (a) identification of bacterial RNAP (diagnostics, environmental-monitoring, and sensors applications), (b) labeling of bacterial RNAP (diagnostics, environmental-monitoring, imaging, and sensors applications), (c) immobilization of bacterial RNAP (diagnostics, environmental-monitoring, and sensors applications), (d) purification of bacterial RNA polymerase (biotechnology applications), (e) regulation of bacterial gene expression (biotechnology applications), and (f) antisepsis (antiseptics, disinfectants, and advanced-materials applications).

USPTO Webpage 7442762

Peach tree named `NJ350`: PP19,382

Inventor(s): Goffreda Joseph C, Voordeckers Anna M

Issued: 10/28/2008

Abstract: A new and distinct peach variety of Prunus persica named `NJ350` is provided. This variety is distinguished from other peach varieties by its unique combination of nonshowy flowers, fruit that ripen early in the season, attractive fruit with an orange-red ground color, clingstone fruit with a juicy, melting texture and moderately acidic flavor, and good production of firm fruit with a low incidence of split pits for the season.

USPTO Webpage PP19,382

Tuesday, October 21, 2008

Three-phase partitioning method for purifying a protein: 7439337

Inventor(s): Ward William W

Issued: 10/21/2008

Abstract: The present invention is a kit and method for purifying a protein of interest.

There is a growing need in the biotechnology, biopharmaceutical, and research fields for a fast, efficient, versatile, and inexpensive low volume, one-step, micro-scale method, in kit form, to prepare small quantities of proteins for early-stage exploratory research. To move forward with early-stage exploratory research, it is essential to be able to quantitate the levels of the proteins of interest and to remove substances that might interfere with the properties and functions of these proteins. Protein quantitation is often accomplished via in vitro quantitative assays such as those employing optical detection methods. Such assay methods include, but are not limited to, colorimetry, fluorimetry, spectrophotometry, microtitre plate scanning, and optical microfluidics. Each of these optical assay methods suffers greatly in accuracy, producing falsely high and, on occasion, falsely low signals, if the sample in question contains unwanted, optically absorptive contaminants or if the sample is cloudy or turbid. Specific interference may occur, on a case-by-case basis, from substances that chemically react with assay reagents or that inhibit development of the assay in some fashion, as in the case of enzyme inhibitors. Thus, for accurate quantification of the protein of interest, removal of such contaminants is essential.

USPTO Webpage 7439337

Tuesday, September 30, 2008

Peach tree named `NJF18`: PP19,273

Inventor(s): Goffreda Joseph C, Voordeckers Anna M

Issued: 9/30/2008

Abstract: A new and distinct peach variety of Prunus persica named `NJF18` is provided. This variety is distinguished from other peach varieties by its unique combination of showy flowers that are medium in width, flat fruit that ripen in early midseason with mottled red over color on an attractive orange ground color, semi-clingstone fruit with a juicy, melting texture and sweet, mild flavor, firm fruit that retain their firmness well and trees with regular, heavy production of large fruit.

USPTO Webpage PP19,273

Tuesday, August 12, 2008

Synthesis of polyanhydrides: 7411031

Inventor(s): Uhrich Kathryn E, Schmeltzer Robert C, Anastasiou Theodore James

Issued: 8/12/2008

Abstract: The present invention provides a method for forming compounds of Formula HO--C(.dbd.O)R.sup.1--X--R.sup.2--X--R.sup.1--C(.dbd.O)--O--H wherein compound (I) can be polymerized to provide a polymer that contains therapeutically active compounds. In the compounds of the invention, each R.sup.1 is group that will provide the therapeutically active compound upon hydrolysis of the polymer; each X is independently an ester linkage or an amide linkage; and R.sup.2 is a linking group.

USPTO Webpage 7411031

Tuesday, August 5, 2008

Nanostructured re-doped SiO.sub.2-base fluorescent materials and methods for production of same: 7407604

Inventor(s): Kear Bernard H, Haines Christopher D, Sigel George H, Klein Lisa C, Ranganathan Varadh

Issued: 8/5/2008

Abstract: A new class of nanostructured RE-doped SiO.sub.2-base materials that display superior fluorescence properties is provided. In particular, high gain combined with a broad and flat spectral band width is observed in material composed of a high fraction of a nano-dispersed metastable silicate phase in a glassy SiO.sub.2 matrix, produced by partial devitrification (crystallization) of several glassy Al.sub.2O.sub.3/Er.sub.2O.sub.3- and Y.sub.2O.sub.3/Er.sub.2O.sub.3-doped SiO.sub.2 compositions. Also, a highly deconvoluted spectral emission, with several prominent peaks, is observed in completely devitrified material, consisting of a uniform nano-dispersion of an equilibrium silicate phase in a crystobalite SiO.sub.2 matrix. Such enhanced fluorescence properties were observed in heat treated nanopowders prepared by vapor-phase, solgel, rapid solidification, and spray-pyrolysis methods.

USPTO Webpage 7407604

Tuesday, July 15, 2008

Schottky diode with silver layer contacting the ZnO and Mg.sub.xZn.sub.1-xO films: 7400030

Inventor(s): Lu Yicheng, Sheng Haifeng, Muthukumar Sriram, Emanetoglu Nuri William, Zhong Jian, Liang Shaohua

Issued: 7/15/2008

Abstract: In the present invention, there is provided semiconductor devices such as a Schottky UV photodetector fabricated on n-type ZnO and Mg.sub.xZn.sub.1-xO epitaxial films. The ZnO and Mg.sub.xZn.sub.1-xO films are grown on R-plane sapphire substrates and the Schottky diodes are fabricated on the ZnO and Mg.sub.xZn.sub.1-xO films using silver and aluminum as Schottky and ohmic contact metals, respectively. The Schottky diodes have circular patterns, where the inner circle is the Schottky contact, and the outside ring is the ohmic contact. Ag Schottky contact patterns are fabricated using standard liftoff techniques, while the Al ohmic contact patterns are formed using wet chemical etching. These detectors show low frequency photoresponsivity, high speed photoresponse, lower leakage current and low noise performance as compared to their photoconductive counterparts. This invention is also applicable to optical modulators, Metal Semiconductor Field Effect Transistors (MESFETs) and more.

USPTO Webpage 7400030

Tuesday, July 8, 2008

Antibiotic polymers: 7396527

Inventor(s): Uhrich Kathryn E

Issued: 7/8/2008

Abstract: Polymers (i.e. polyesters, polyamides, polythioesters, polyanhydrides, or a mixture thereof) which degrade hydrolytically to provide a combination of a beta-lactam antibiotic (e.g., amoxicillin) and a beta-lactamase inhibitor (e.g., clavulanic acid) (or a pharmaceutically acceptable salt thereof) are provided. Methods of producing these polymers, intermediates useful for preparing these polymers, and methods of using these polymers to deliver a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor (or a pharmaceutically acceptable salt thereof) to a host are also provided.

USPTO Webpage 7396527

Tuesday, June 10, 2008

Animal model, cells, and treatment for malignant melanoma: 7385103

Inventor(s): Chen Suzie

Issued: 6/10/2008

Abstract: The present invention provides transgenic non-human animal models and cell lines which express a metabotropic glutamate receptor 1 in a melanocyte-specific manner and, as a result, exhibit a predisposition to the development of melanoma. The invention further teaches methods of using the transgenic animals and cell lines to identify therapeutic agents. Diagnostic methods for detecting a melanoma are also provided.

USPTO Webpage 7385103

Tuesday, June 3, 2008

Reagents and procedures for multi-label high-specificity labeling: 7381572

Inventor(s): Ebright Richard H, Ebright Yon W

Issued: 6/3/2008

Abstract: A detectable complex and methods for use thereof are provided herein. The detectable complex includes: at least one target material; a first peptide tag bound to the at least one target material; and a second peptide tag bound to the at least one target material. The complex further includes a first conjugate having a detectable group and two pendant phenylarsine moieties comprising a first tag binding group; wherein the first conjugate preferentially associates with the first peptide tag; and a second conjugate having a detectable group and two pendant phenylarsine moieties comprising a second tag binding group; wherein the second conjugate preferentially associates with the second peptide tag. The mean distance and/or mean angle between the pendant phenylarsine moieties in the first conjugate is different from the mean distance and/or mean angle between the pendant phenylarsine moieties in the second conjugate. Further provided herein are useful peptide tag combinations, target materials or sets of target materials including these peptide tag combinations, and nucleic acids or nucleic acid sets encoding these compositions.

USPTO Webpage 7381572

Tuesday, May 13, 2008

Antioxidant and anti-inflammatory activity of compounds and preparations from African nutmeg seeds: 7371413

Inventor(s): Simon James E, Wang Mingfu, Gbewonyo Kodzo, Rafi Mohamed M, Acquaye Daniel Fahene, Asianowa Yaw

Issued: 5/13/2008

Abstract: The present invention provides methods for reducing the production of nitric oxide, inducible nitric oxide synthase protein and mRNA, and cyclooxygenase-2 protein and mRNA in cells both in vivo and in vitro via the administration of extracts and compounds derived from the seeds of Pycnanthus angolensis Warb. (P. Kombo), commonly known as African nutmeg. These extracts and compounds, namely, kombo butter, kombo butter acid extract, sargaquinoic acid, sargachromenol, and sargahydroquinoic acid, are also useful in the treatment and prevention of a battery of adverse health conditions in human, animal, and avian subjects that are advanced by the production of nitric oxide or its metabolites and/or by the activity of cyclooxygenase-2. Methods for the isolation of kombo butter acid extracts are also provided.

USPTO Webpage 7371413